Inhibition of Epstein-Barr Virus (EBV) Laten Membrane Protein 2A (LMP2A) signal transduction in order to enhance apoptosis in B Lymphocytes expressing LMP2A: A therapeutic target for latent EBV infection and EBV-associated lymphomas

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/102/28/11

Funding

  • Ann & Robert H. Lurie Children's Hospital of Chicago (Ltr dtd 2/11/2010)
  • Children's Research Foundation (Ltr dtd 2/11/2010)